食道癌:炎症标志物的现状和新见解 - - 一个简短的回顾
相关实验视频
Updated: Jun 22, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
400
Bartłomiej Strzelec1, Piotr Paweł Chmielewski2, Wojciech Kielan3
12nd Department of General and Oncological Surgery, Wroclaw Medical University, Wroclaw, Poland.
Polski przeglad chirurgiczny
|June 28, 2024
概括
食道癌 (EC) 是一个全球性的健康挑战. 评估血清细胞因子水平为早期EC检测和改善患者结果提供了一种安全方法.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 炎症研究 炎症研究
背景情况:
- 食道癌 (EC) 对全球癌症发病率和死亡率作出重大贡献.
- 疾病发病过程涉及遗传和环境因素,亚型流行率在区域上有差异 (例如,西部的EAC,东部的ESCC).
- 慢性炎症是EC开始和进展的关键驱动因素.
研究的目的:
- 审查主要的风险因素和对食道癌的当前理解.
- 探索新型炎症标志物的潜力,以提高EC诊断,预后和管理.
- 突出血清细胞因子水平对于EC预测的临床有用性.
主要方法:
- 文献综述侧重于食道癌流行病学,风险因素和炎症标志物.
- 分析慢性炎症和细胞因子在EC发育中的作用.
- 讨论欧洲共同体当前的诊断和预后方法.
主要成果:
- 血清炎症标志物,生长因子和细胞因子在EC中显示出临床效用.
- 评估血清细胞因子水平是用于EC预测的安全和可行的查方法.
- 由于EC的侵略性和预后不佳,创新的诊断和预后策略至关重要.
结论:
- 血清细胞因子评估代表了食道癌查的有希望,安全和可行的方法.
- 新型炎症标志物有可能改善EC的管理和患者的治疗结果.
- 对炎症标志物的进一步研究对于推进EC护理至关重要.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
135
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
135
Barrett Esophagus-I: Introduction
83
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
83
Esophageal Strictures-I: Introduction
81
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
81
Esophageal Strictures-II: Clinical Features and Management
61
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
61
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
109
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
109
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

